-
8 Articles
-
0 Photos
-
0 Vidéos
-
Suivi par 0 membre
© 2026 Bondhusova - The Hunger Fighter
French
Mises à jour récentes
-
Phage Display Ushers in a New Era of Precision Antibody EngineeringAs biopharmaceutical pipelines expand and therapeutic modalities grow more complex, the demand for highly specific, reproducible, and customizable antibodies has never been greater. Two categories—post‑translational modification (PTM)–specific antibodies and anti‑idiotype (anti‑ID) antibodies—have become essential tools for both discovery research and regulated bioanalytical...0 Commentaires 0 Parts 39 Vue 0 AperçuConnectez-vous pour aimer, partager et commenter!
-
T4 Phage Display: Expanding the Possibilities of Next-Generation BiotechnologyAs biotechnology advances toward increasingly complex therapeutics and vaccine platforms, researchers are seeking display technologies that offer greater flexibility, stability, and cargo capacity. While traditional phage display systems such as M13 remain widely used, they can face limitations when presenting large or structurally complex proteins. In response, the T4 bacteriophage has emerged...0 Commentaires 0 Parts 26 Vue 0 Aperçu
-
Building Better In Vitro Models for Neuroscience ResearchAdvanced neuroscience research increasingly relies on models that balance biological relevance, reproducibility, and scalability. Cell culture, cell line, and 3D models offer complementary strategies for studying neurological diseases. Neurological disease research continues to face a fundamental challenge: the human nervous system is extraordinarily complex, while experimental models...0 Commentaires 0 Parts 43 Vue 0 Aperçu
-
3D Neural Spheroids: Why Better Models Need Better AssaysA drug candidate can maintain cell viability while altering neuronal activity.. Discover how 3D neural spheroids, fit-for-purpose assays, and reproducibility controls can help researchers make more confident early screening decisions. A drug candidate can leave cultured neurons alive while changing how they communicate. A viability-only screen might miss that signal. For neuroscience...0 Commentaires 0 Parts 30 Vue 0 Aperçu
-
Beyond Complement Levels: Why Functional Testing MattersComplement research increasingly demands more than the quantification of individual proteins. Functional assays, pathway-specific testing, and standardized assay solutions can help researchers better characterize complement activity, manage experimental variability, and generate data with greater biological relevance. The Challenge: Measuring Presence Does Not Always Reveal Function The...0 Commentaires 0 Parts 58 Vue 0 Aperçu
-
Complement Testing: Why One Readout Can Mislead Drug ResearchComplement inhibitors can generate seemingly conflicting assay results because pathway function, activation products, and C3b deposition capture different events. Learn how to select complementary readouts and reduce the risk of interpretation errors. An experimental inhibitor reduces complement-mediated cell lysis, yet C3b remains detectable on the same target cells. Is the candidate...0 Commentaires 0 Parts 64 Vue 0 Aperçu
-
CRISPR Editing Worked—But Is the Disease Model Fit for Purpose?CRISPR has made targeted genome editing faster and more accessible, yet one persistent challenge remains: a successful on-target edit does not necessarily produce a reliable research model. For researchers using CRISPR in disease modeling, target validation, or drug discovery, editing efficiency is only an early checkpoint. The resulting cells must also carry the intended genotype,...0 Commentaires 0 Parts 75 Vue 0 Aperçu
-
Viral Vector QC Gaps: Why Gene Therapy Programs Stall Before ClinicFragmented viral vector QC can delay gene therapy development. rcAAV detection failures, identity mischaracterization, and siloed workflows are key pain points. Integrated orthogonal testing can reduce quality gaps and support IND preparation. Viral vectors drive the gene therapy revolution — yet quality control (QC) remains the industry's Achilles' heel. As AAV, lentiviral, and...0 Commentaires 0 Parts 74 Vue 0 Aperçu
Plus de lecture
Commandité